Ranibizumab dose-capping scheme proposed

THE NHS will pay for a maximum of 14 injections of ranibizumab (Lucentis) per eye for patients with macular degeneration, under new draft guidelines launched today.



Sign in

In order to continue you need to be a registered user. If you would like to register to Nursing Times then click here.

Already Registered

New User?

If you are a new user and would like to register to Nursing Times then click here.



Register

Forgotten Password / Username

Enter your email *